Spin-Off
Commented by Armin Schulz on October 14th, 2026 | 05:41 CEST
Barrick Mining, Lahontan Gold and Agnico Eagle: Gold Stocks Spanning Production, Mine Restart and Strategic Investments
Since 2019, Barrick Mining has invested about USD 5.3 billion in Tanzania's economy, according to its own figures, and it extended the licences for the North Mara gold mine by 15 years in early October. This provides planning certainty. Smaller companies also have big plans. Lahontan Gold agreed to acquire Emergent Metals in mid-September and is targeting a 2027 restart of the Santa Fe mine in Nevada. If it succeeds, the high gold price works in the company's favour. Agnico Eagle shows that major producers are also interested in emerging companies. We therefore take a closer look at Barrick Mining, Lahontan Gold and Agnico Eagle.
Read
Commented by André Will-Laudien on July 29th, 2026 | 07:50 CEST
Active Ingredients, Acquisitions and Spin-offs: Will Bayer, Novo Nordisk, BioNxt, or Evotec Become Top M&A Targets?
After years of consolidation, investors are asking: Will things start looking up again? The global life sciences sector is facing another massive wave of consolidation in 2026 as established pharmaceutical giants and agile biotech pioneers realign their businesses. Market dynamics remain high, but unfortunately, both sides are being exploited. So far, it has been predominantly speculative investors who are capitalizing on the current volatility. Following drastic share price losses and ongoing restructuring, the struggling Hamburg-based biotech company Evotec is increasingly in the crosshairs of financially strong acquirers seeking to acquire high-calibre drug discovery platforms at a bargain price. At the same time, BioNxt is attracting investor interest with its groundbreaking drug delivery systems and advanced clinical pipelines. Meanwhile, the market continues to speculate feverishly about a possible breakup or spin-off of individual divisions at the DAX-listed Bayer Group, which would massively increase its appeal to strategic buyers. On the other hand, Danish industry leader Novo Nordisk, driven by the sustained billion-dollar profits from its weight-loss portfolio, is acting as a financially powerful hunter in search of strategic acquisitions in the obesity and cardiovascular segments. For investors, this highly dynamic environment offers a rare opportunity to bet early on the year's hottest takeover candidates. What is the current status?
Read
Commented by Carsten Mainitz on February 4th, 2026 | 07:20 CET
Profits with a plan: Spin-offs as return drivers – Now it is Pure One's turn, Infineon and TKMS have shown the way!
The market often undervalues complex companies. Spin-offs - the separation of a division, technology, or subsidiary from an existing company - are a proven way to make hidden value visible. Investors can benefit from this, often with clear advance notice. One of the most well-known spin-offs is PayPal. In 2015, eBay shareholders received 0.22 PayPal shares for each eBay share held. Today, PayPal is one of the world's largest payment service providers. The Australian company Pure One will soon be listing its highly sought-after gas activities on the stock exchange via an IPO. This is an opportunity investors should not miss.
Read
Commented by Mario Hose on September 16th, 2020 | 10:05 CEST
Blackrock Gold, Continental, Siemens: Spin-Off as driver of share price
In the case of growing and large companies, the decision may be made in the course of development that part of the operational business be formed into a separate entity. A so-called spin-off or spin-out can have various advantages. On the one hand, capital-intensive businesses can separately tap the capital market independently in the form of a stock exchange listing and, in addition, the original company can also use the opportunity to sell shares. On the capital market, spin-off rumors and announcements can generate great interest among investors.
Read